Benzodiazepine Drugs Market (Product - Alprazolam, Clonazepam, Diazepam, Lorazepam; Application - Anxiety, Insomnia, Alcohol Withdrawal, Seizures; Time of Action - Ultra-short Acting, Short Acting, Long Acting; Distribution Channel - Hospitals Pharmacies, Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2030

Benzodiazepine drugs are psychoactive drug that are used to treat disorders such as anxiety, insomnia, panic disorder, and alcohol addiction. These drugs provide a soothing effect by enhancing the neurotransmitter GABA. The use of benzodiazepine drugs has served many people to balance their anxiety syndrome and lead a normal life. Taking into consideration the current scenario of stressful and hectic lifestyle, the benzodiazepine drugs market is anticipated to grow at a rapid rate.

According to the recent studies by World Health Organization (WHO), there is a substantial increase in cases of anxiety disorders among male and female population. However, the percentage of female population with anxiety disorder is more as compared to male population. These statistics have been vital in driving the growth parameters of the benzodiazepine drugs market.

Rapid urbanization and modern work culture have a significant influence on the mental health of people.. There is noteworthy increase in issues such as insomnia, anxiety, and depression due to excessive use of technology and high work pressure. Furthermore, the geriatric population is suffering largely with sleep and panic disorders. Rise in awareness among the masses about the importance of mental health has boosted the demand for diagnosis and medication. In addition, sizable demand for therapies such as cognitive behavior therapy (CBT) and effective anti-depressants is observed in the recent years. The aforementioned factors are creating substantial growth prospects in the benzodiazepine drugs market.

The benzodiazepine drugs market has been categorized into long acting, short acting and ultra-short acting. Players in the benzodiazepine drugs market are focusing strengthening their distribution channels, which include hospitals, pharmacies, retail pharmacies, online and mail pharmacies.

The key market players are investing in R&D activities to enhance the effectiveness of benzodiazepine drugs used for sedation, inducing sleep, and anxiety reduction with minimal side effects. Moreover, companies are investing in small start-ups and using varied strategies such as mergers, acquisitions, joint ventures, and partnerships in order to maintain their dominance in the benzodiazepine drugs market.

Benzodiazepine Drugs Market - Snapshot

Benzodiazepines is a class of psychoactive drugs that are used to treat anxiety, insomnia, panic disorder, seizures, and alcohol withdrawal. These drug produce a calming effect by enhancing the effect of the neurotransmitter GABA. Benzodiazepines are widely prescribed drugs across the world. They are helpful to reduce anxiety, seizures, relax muscles, inducing sleep, and used for sedation purposes prior to surgery or general anesthesia. The global benzodiazepine drugs market was valued at around US $ 2,055 Mn in 2017. It is expected to expand at a CAGR of 2.7% from 2018 to 2026. The Alprazolam segment dominates the global market in terms of value. The market for benzodiazepine drugs is expanding significantly due to the rise in prevalence of anxiety, seizures, insomnia, and increase in concern among people about preventive measures regarding stress-related conditions. Increased adoption of generic drugs and comparatively higher prescriptions for benzodiazepines, as compared to other psychoactive drugs, also drive the market.

benzodiazepine drugs market

The benzodiazepine drugs market has been segmented based on product, application, time of action, distribution channel, and region. Based on product, the global market has been divided into Alprazolam, Clonazepam, Diazepam, Lorazepam, and others. The Alprazolam segment dominated the global market in 2017. It is projected to expand at a higher CAGR due to more number of prescriptions and wide applications in anxiety and seizures. Based on application, the global benzodiazepine drugs market has been classified into anxiety, insomnia, alcohol withdrawal, seizures, and others. Anxiety was the dominant segment of the market in 2017. It is expected to expand at a higher CAGR, owing to the rise in prevalence of anxiety and panic disorders and the better calming effect produced by benzodiazepines. In terms of time of action, the global benzodiazepine drugs market has been classified into ultra-short acting, short acting, and long acting. The short acting segment dominated the market in 2017. It is expected to maintain its position due to less hangover effect and faster onset of action. Based on distribution channel, the global benzodiazepine drugs market has been segregated into hospital pharmacies, retail pharmacies, and others. The others segment, which comprises online pharmacies and mail pharmacies, is projected to expand at a significantly higher CAGR during the forecast period. This expanded CAGR is attributed to discounted prices and convenience of usage.

 In terms of region, the global benzodiazepine drugs market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global benzodiazepine drugs market in 2017, owing to the rise in prevalence of anxiety and related conditions and higher FDA approvals of benzodiazepine drugs by major players in the region. Asia Pacific and Latin America are potential markets for benzodiazepine drugs due to increased awareness of people toward healthcare, stress conditions, and surge in healthcare expenditure.

Key players operating in the global benzodiazepine drugs market include Pfizer Inc., F.Hoffmann-La Roche Ltd., Bausch Health Companies, Inc., Mylan, N.V., Teva Pharmaceutical Industries Ltd., H.Lundbeck A/S, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Apotex Inc., and Aurobindo Pharma.

Increasing Prevalence of Anxiety and Insomnia Disorders Draws Demand in Benzodiazepines Drugs Market

Global benzodiazepines drugs market is on a steady rise owing to the rising prevalence of anxiety disorders and increased levels of stress in global population. Stressful and fast paced lifestyles along with unhealthy work life balance are some of the contributory factors that precede mental health disturbances. Rising number of millennial population is prone to depression and comorbid anxiety disorders. According to a report issued by the World Health Organization (WHO) in 2015, the estimated number of people suffering from anxiety disorders around the world was 264 million at the time. Unhealthy social comparisons enabled by extended usage of social networking platforms among teenagers and millennials is one of the factors contributing to this growth in mental health disorders. Growing global geriatric population and high prevalence of insomnia or other sleep disorders are some of the key motivators for global benzodiazepines drugs market.

Products in global benzodiazepines drugs market are used for sedation, sleep inducing, and reducing anxiety. They can be both, short acting or long acting, depending on the type of product. Short acting drugs have greater risk of patient suffering from withdrawal symptoms. However, they work really well in the treatment of panic disorders. Long acting drugs in benzodiazepines drugs market have longer half-life, so the drug remains in the system for a longer time, working slowly. Withdrawal symptoms for long acting drugs are not as intense as the short acting ones, as they give the patient a prolonged period of time to adjust to the drug leaving the system. Use of products in benzodiazepines drug market assists countless people to manage their anxiety and lead a normal and safe life. However, benzodiazepine drugs can be abused as it induces sleep and causes sedation. Instances of benzodiazepine overdose can lead to the death of the consumer. These factors may hinder the growth in benzodiazepines drugs market.

The benzodiazepine drugs market has been segmented as follows:

Product

• Alprazolam
• Clonazepam
• Diazepam
• Lorazepam
• Others (Clobazam, Temazepam, Midazolam, Chlordiazepoxide, Clorazepate, Estazolam, Flurazepam, Oxazepam, Triazolam, and Quazepam)

Application

• Anxiety
• Insomnia
• Alcohol Withdrawal
• Seizures
• Others (Muscle spasm, panic disorders, general anesthesia, depression, Lennox-Gastaut syndrome, and maniac conditions)

Time of Action

• Ultra-short Acting
• Short Acting
• Long Acting

Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Others (Online Pharmacies, Mail Pharmacies, and Home Care Pharmacies)

Region

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of LATAM
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Benzodiazepine Drugs Market

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Benzodiazepine Drugs Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Regulatory Scenario by Region/globally
     5.2. Pipeline Analysis
     5.3. Overview of Growing Benzodiazepine Drug Misuse

6. Global Benzodiazepine Drugs Market Analysis and Forecast, by Product 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            6.3.1. Alprazolam
            6.3.2. Clonazepam
            6.3.3. Diazepam
            6.3.4. Lorazepam
            6.3.5. Others
     6.4. Global Benzodiazepine Drugs Market Attractiveness, by Product

7. Global Benzodiazepine Drugs Market Analysis and Forecast, by Application
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            7.3.1. Anxiety
            7.3.2. Insomnia
            7.3.3. Alcohol Withdrawal
            7.3.4. Seizures
            7.3.5. Others
     7.4. Global Benzodiazepine Drugs Market Attractiveness, by Application

8. Global Benzodiazepine Drugs Market Analysis and Forecast, by Time of Action
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Global Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            8.3.1. Ultra-short Acting
            8.3.2. Short Acting
            8.3.3. Long Acting
     8.4. Global Benzodiazepine Drugs Market Attractiveness, by Time of Action

9. Global Benzodiazepine Drugs Market Analysis and Forecast, by Distribution Channel
     9.1. Introduction & Definition
     9.2. Key Findings / Developments
     9.3. Global Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            9.3.1. Hospital Pharmacies
            9.3.2. Retail Pharmacies
            9.3.3. Others
     9.4. Global Benzodiazepine Drugs Market Attractiveness, by Distribution Channel

10. Global Benzodiazepine Drugs Market Analysis and Forecast, by Region
     10.1. Key Findings
     10.2. Global Benzodiazepine Drugs Market Value Forecast, by Region
            10.2.1. North America 
            10.2.2. Europe 
            10.2.3. Asia Pacific 
            10.2.4. Latin America 
            10.2.5. Middle East and Africa 
     10.3. Global Benzodiazepine Drugs Market Attractiveness, by Region

11. North America Benzodiazepine Drugs Market Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. North America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            11.2.1. Alprazolam
            11.2.2. Clonazepam
            11.2.3. Diazepam
            11.2.4. Lorazepam
            11.2.5. Others
     11.3. North America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            11.3.1. Anxiety
            11.3.2. Insomnia
            11.3.3. Alcohol Withdrawal
            11.3.4. Seizures
            11.3.5. Others
     11.4. North America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
                   11.4.1. Ultra-short Acting
            11.4.2. Short Acting
            11.4.3. Long Acting
     11.5. North America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            11.5.1. Hospital Pharmacies
            11.5.2. Retail Pharmacies
            11.5.3. Others
     11.6. North America Benzodiazepine Drugs Market Value Forecast, by Country, 2016–2026
            11.6.1. U.S.
            11.6.2. Canada
     11.7. North America Benzodiazepine Drugs Market Attractiveness Analysis 
            11.7.1. By Product 
            11.7.2. By Application 
            11.7.3. By Time of Action
            11.7.4. By Distribution Channel
            11.7.5. By Country

12. Europe Benzodiazepine Drugs Market Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Europe Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            12.2.1. Alprazolam
            12.2.2. Clonazepam
            12.2.3. Diazepam
            12.2.4. Lorazepam
            12.2.5. Others
     12.3. Europe Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            12.3.1. Anxiety
            12.3.2. Insomnia
            12.3.3. Alcohol Withdrawal
            12.3.4. Seizures
            12.3.5. Others
     12.4. Europe Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            12.4.1. Ultra-short Acting
            12.4.2. Short Acting
            12.4.3. Long Acting
     12.5. Europe Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            12.5.1. Hospital Pharmacies
            12.5.2. Retail Pharmacies
            12.5.3. Others
     12.6. Europe Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            12.6.1. Germany
            12.6.2. U.K.
            12.6.3. France
            12.6.4. Italy
            12.6.5. Spain
            12.6.6. Rest of Europe 
     12.7. Europe Benzodiazepine Drugs Market Attractiveness Analysis 
            12.7.1. By Product 
            12.7.2. By Application 
            12.7.3. By Time of Action
            12.7.4. By Distribution Channel
            12.7.5. By Country/Sub-region

13. Asia Pacific Benzodiazepine Drugs Market Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            13.2.1. Alprazolam
            13.2.2. Clonazepam
            13.2.3. Diazepam
            13.2.4. Lorazepam
            13.2.5. Others
     13.3. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            13.3.1. Anxiety
            13.3.2. Insomnia
            13.3.3. Alcohol Withdrawal
            13.3.4. Seizures
            13.3.5. Others
     13.4. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            13.4.1. Ultra-short Acting
            13.4.2. Short Acting
            13.4.3. Long Acting
     13.5. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            13.5.1. Hospital Pharmacies
            13.5.2. Retail Pharmacies
            13.5.3. Others
     13.6. Asia Pacific Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            13.6.1. China
            13.6.2. India
            13.6.3. Japan
            13.6.4. Australia & New Zealand
            13.6.5. Rest of APAC
     13.7. Asia Pacific Benzodiazepine Drugs Market Attractiveness Analysis 
            13.7.1. By Product 
            13.7.2. By Application 
            13.7.3. By Time of Action
            13.7.4. By Distribution Channel
            13.7.5. By Country/Sub-region

14. Latin America Benzodiazepine Drugs Market Analysis and Forecast
     14.1. Introduction
            14.1.1. Key Findings
     14.2. Latin America Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            14.2.1. Alprazolam
            14.2.2. Clonazepam
            14.2.3. Diazepam
            14.2.4. Lorazepam
            14.2.5. Others
     14.3. Latin America Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            14.3.1. Anxiety
            14.3.2. Insomnia
            14.3.3. Alcohol Withdrawal
            14.3.4. Seizures
            14.3.5. Others
     14.4. Latin America Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            14.4.1. Ultra-short Acting
            14.4.2. Short Acting
            14.4.3. Long Acting
     14.5. Latin America Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            14.5.1. Hospital Pharmacies
            14.5.2. Retail Pharmacies
            14.5.3. Others
     14.6. Latin America Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            14.6.1. Brazil
            14.6.2.Mexico
            14.6.3. Rest of LATAM 
     14.7. Latin America Benzodiazepine Drugs Market Attractiveness Analysis 
            14.7.1. By Product 
            14.7.2. By Application 
            14.7.3. By Time of Action
            14.7.4. By Distribution Channel
            14.7.5. By Country/Sub-region

15. Middle East & Africa Benzodiazepine Drugs Market Analysis and Forecast
     15.1. Introduction
            15.1.1. Key Findings
     15.2. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Product, 2016–2026
            15.2.1. Alprazolam
            15.2.2. Clonazepam
            15.2.3. Diazepam
            15.2.4. Lorazepam
            15.2.5. Others
     15.3. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Application, 2016–2026
            15.3.1. Anxiety
            15.3.2. Insomnia
            15.3.3. Alcohol Withdrawal
            15.3.4. Seizures
            15.3.5. Others
     15.4. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Time of Action, 2016–2026
            15.4.1. Ultra-short Acting
            15.4.2. Short Acting
            15.4.3. Long Acting
     15.5. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Distribution Channel, 2016–2026
            15.5.1. Hospital Pharmacies
            15.5.2. Retail Pharmacies
            15.5.3. Others
     15.6. Middle East & Africa Benzodiazepine Drugs Market Value Forecast, by Country/Sub-region, 2016–2026
            15.6.1. GCC Countries
            15.6.2.South Africa
            15.6.3. Rest of MEA
     15.7. Middle East & Africa Benzodiazepine Drugs Market Attractiveness Analysis 
            15.7.1. By Product 
            15.7.2. By Application 
            15.7.3. By Time of Action
            15.7.4. By Distribution Channel
            15.7.5. By Country/Sub-region

16. Competition Landscape
     16.1.Market Player – Competition Matrix (By Tier and Size of companies)
     16.2.Market Share Analysis By Tier and Size of the Company (2017)
     16.3. Company Profiles
            16.3.1. Pfizer Inc.
            16.3.2. F.Hoffmann-La Roche Ltd.
            16.3.3. Bausch Health Companies, Inc.
            16.3.4. Mylan N.V. 
            16.3.5. Teva Pharmaceutical Industries Ltd. 
            16.3.6. H.Lundbeck A/S 
            16.3.7. Amneal Pharmaceuticals LLC 
            16.3.8. Sun Pharmaceutical Industries Ltd.
            16.3.9. Apotex Inc. 
            16.3.10. Aurobindo Pharma